Tata Chemicals Limited (BOM:500770)
699.00
-10.70 (-1.51%)
At close: Feb 12, 2026
Tata Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 146,550 | 148,870 | 154,210 | 167,890 | 126,220 | 101,998 | |
Revenue Growth (YoY) | -1.33% | -3.46% | -8.15% | 33.01% | 23.75% | -1.52% |
Cost of Revenue | 58,000 | 59,450 | 61,060 | 68,640 | 51,970 | 28,180 |
Gross Profit | 88,550 | 89,420 | 93,150 | 99,250 | 74,250 | 73,818 |
Selling, General & Admin | 51,160 | 48,990 | 42,800 | 40,600 | 34,660 | 15,331 |
Other Operating Expenses | 18,400 | 20,490 | 20,870 | 19,530 | 15,860 | 42,779 |
Operating Expenses | 81,090 | 80,730 | 73,580 | 69,080 | 58,760 | 65,703 |
Operating Income | 7,460 | 8,690 | 19,570 | 30,170 | 15,490 | 8,116 |
Interest Expense | -4,850 | -4,740 | -4,300 | -3,250 | -2,270 | -2,863 |
Interest & Investment Income | 1,130 | 1,130 | 1,900 | 1,160 | 1,410 | 948.8 |
Earnings From Equity Investments | 1,580 | 1,540 | 680 | -20 | 2,260 | 256.2 |
Currency Exchange Gain (Loss) | 50 | 50 | -470 | -300 | -70 | -234.6 |
Other Non Operating Income (Expenses) | 180 | -710 | -870 | -740 | -660 | -554 |
EBT Excluding Unusual Items | 5,550 | 5,960 | 16,510 | 27,020 | 16,160 | 5,669 |
Merger & Restructuring Charges | -550 | -1,250 | - | - | -110 | - |
Gain (Loss) on Sale of Investments | 510 | 510 | 490 | 570 | 580 | 610 |
Gain (Loss) on Sale of Assets | 40 | 40 | -30 | 20 | -140 | -57.9 |
Asset Writedown | -70 | -70 | -9,720 | -300 | - | - |
Legal Settlements | - | - | 1,020 | - | - | - |
Other Unusual Items | -1,190 | - | - | - | - | - |
Pretax Income | 4,310 | 5,210 | 8,300 | 27,400 | 16,670 | 6,340 |
Income Tax Expense | 970 | 1,670 | 3,810 | 2,880 | 2,670 | 1,978 |
Earnings From Continuing Operations | 3,340 | 3,540 | 4,490 | 24,520 | 14,000 | 4,362 |
Earnings From Discontinued Operations | 180 | 330 | -140 | -180 | 50 | - |
Net Income to Company | 3,520 | 3,870 | 4,350 | 24,340 | 14,050 | 4,362 |
Minority Interest in Earnings | -1,720 | -1,520 | -1,670 | -1,170 | -1,470 | -1,799 |
Net Income | 1,800 | 2,350 | 2,680 | 23,170 | 12,580 | 2,564 |
Net Income to Common | 1,800 | 2,350 | 2,680 | 23,170 | 12,580 | 2,564 |
Net Income Growth | - | -12.31% | -88.43% | 84.18% | 390.70% | -96.34% |
Shares Outstanding (Basic) | 255 | 255 | 255 | 255 | 255 | 255 |
Shares Outstanding (Diluted) | 255 | 255 | 255 | 255 | 255 | 255 |
EPS (Basic) | 7.07 | 9.22 | 10.52 | 90.95 | 49.38 | 10.06 |
EPS (Diluted) | 7.07 | 9.22 | 10.52 | 90.95 | 49.38 | 10.06 |
EPS Growth | - | -12.31% | -88.43% | 84.18% | 390.70% | -96.34% |
Free Cash Flow | - | -2,440 | 11,820 | 13,930 | 3,680 | 7,954 |
Free Cash Flow Per Share | - | -9.58 | 46.40 | 54.68 | 14.45 | 31.22 |
Dividend Per Share | - | 11.000 | 15.000 | 17.500 | 12.500 | 10.000 |
Dividend Growth | - | -26.67% | -14.29% | 40.00% | 25.00% | -9.09% |
Gross Margin | 60.42% | 60.07% | 60.41% | 59.12% | 58.83% | 72.37% |
Operating Margin | 5.09% | 5.84% | 12.69% | 17.97% | 12.27% | 7.96% |
Profit Margin | 1.23% | 1.58% | 1.74% | 13.80% | 9.97% | 2.51% |
Free Cash Flow Margin | - | -1.64% | 7.66% | 8.30% | 2.92% | 7.80% |
EBITDA | 18,065 | 18,410 | 28,110 | 39,050 | 23,500 | 14,657 |
EBITDA Margin | 12.33% | 12.37% | 18.23% | 23.26% | 18.62% | 14.37% |
D&A For EBITDA | 10,605 | 9,720 | 8,540 | 8,880 | 8,010 | 6,542 |
EBIT | 7,460 | 8,690 | 19,570 | 30,170 | 15,490 | 8,116 |
EBIT Margin | 5.09% | 5.84% | 12.69% | 17.97% | 12.27% | 7.96% |
Effective Tax Rate | 22.51% | 32.05% | 45.90% | 10.51% | 16.02% | 31.19% |
Revenue as Reported | 149,690 | 151,120 | 157,070 | 170,070 | 128,780 | 104,342 |
Advertising Expenses | - | 1,000 | 1,100 | 1,350 | 770 | 812.2 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.